Ms Nancy J Killen, LCSW-C | |
5074 Dorsey Hall Dr, Suite 104, Ellicot City, MD 21042 | |
(301) 236-0626 | |
(301) 388-0896 |
Full Name | Ms Nancy J Killen |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 28 Years |
Location | 5074 Dorsey Hall Dr, Ellicot City, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831122456 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 09931 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Nancy J Killen, LCSW-C 5074 Dorsey Hall Dr, Suite 104, Ellicot City, MD 21042 Ph: (301) 236-0626 | Ms Nancy J Killen, LCSW-C 5074 Dorsey Hall Dr, Suite 104, Ellicot City, MD 21042 Ph: (301) 236-0626 |
News Archive
The NCD Alliance, which represents about 2,000 health organizations from around the world focused on non-communicable diseases (NCDs), "on Thursday accused the United States, Canada and Europe of harming efforts to fight cancer, diabetes, heart and other diseases because they will not agree to set United Nations targets," Reuters reports.
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company announced today that it has published results in the American Journal of Respiratory and Critical Care Medicine from its double-blind, placebo-controlled, randomized Phase IIa study of ALN-RSV01 in lung transplant patients naturally infected with respiratory syncytial virus (RSV).
NPR: "The traditionally male-dominated environment often doesn't recognize that women veterans of the wars in Iraq and Afghanistan have experienced the same psychological, physical and emotional trauma as male veterans." Jill Feldman, manager of the Women Veterans Health Care Program at the Milwaukee VA, says the hospital is working to change a culture that has traditionally been more masculine.
Mutation of a gene involved in non-small cell lung cancer (NSCLC) increases the likelihood that the drug gefitinib (Iressaâ„¢) will show a beneficial response, researchers at the Dana-Farber Cancer Institute, the National Cancer Institute (NCI) - part of the National Institutes of Health - and two other institutions announced today in the online version of Science.
An innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies, report scientists from Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, and Children's Hospital Boston.
› Verified 2 days ago
Mary Durning, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3355 St. John's Lane, Suite F, Ellicot City, MD 21042 Phone: 410-750-2970 Fax: 410-480-0110 |